SCHEMBL8911564

SCHEMBL8911564

C[N+](C)(C)CC(O)OP(=O)([O-])O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A16 Q86VW1 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 3/20 0.33
TSHR P16473 2/20 0.32
CHRM2 P08172 2/20 0.32
CHRM4 P08173 2/20 0.32
CHRM1 P11229 2/20 0.32
TBXA2R P21731 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CYP1A2 P05177 1/20 0.32
HRH1 P35367 1/20 0.32
LMNA P02545 2/20 0.31
CPT2 P23786 1/20 0.31
CPT1A P50416 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM3 P20309 1/20 0.31
CYP2C9 P11712 1/20 0.31
GALR3 O60755 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2553127 0.78 SLC22A16 (0.32) SLC22A16SMN1; SMN2MAPTTSHRCHRM2
SCHEMBL11347712 0.78 SLC22A16 (0.32) SLC22A16SMN1; SMN2MAPTTSHRCHRM2
SCHEMBL737340 0.78 CPT2 (0.38) SLC22A16SMN1; SMN2MAPTTSHRCHRM2
SCHEMBL192296 0.76 MEN1 (0.39) SLC22A16SMN1; SMN2MAPTTSHRMEN1
SCHEMBL5255308 0.76 MEN1 (0.34) SLC22A16SMN1; SMN2MEN1KMT2ACYP1A2
SCHEMBL6236753 0.75 SMN1; SMN2 (0.49) SLC22A16SMN1; SMN2MAPTTSHRCHRM2
SCHEMBL8910736 0.75 LAP3 (0.37) SLC22A16SMN1; SMN2MAPTTSHRCHRM2
SCHEMBL1370014 0.74 SMN1; SMN2 (0.42) SLC22A16SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL29869153 0.73 MEN1 (0.33) SLC22A16MEN1KMT2ACYP1A2HRH1
SCHEMBL14739090 0.73 MEN1 (0.35) SMN1; SMN2MAPTTSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0518959-B1 METHOD OF IMPROVING THE OCULAR HAEMO AND BIOCOMPATIBILITY OF SYNTHETIC POLYMERS BIOCOMPATIBLES LTD (GB) 1996-11-20 EP claimed
US-5591882-A Process for preparing organophosphates useful for increasing the ocular haemo- and biocompatibility of synthetic polymers BIOCOMPATIBLES LIMITED (GB) 1997-01-07 US disclosed
EP-0518959-B1 METHOD OF IMPROVING THE OCULAR HAEMO AND BIOCOMPATIBILITY OF SYNTHETIC POLYMERS BIOCOMPATIBLES LTD (GB) 1996-11-20 EP disclosed
US-5422402-A Surface treatment (of an acrylic, polypropylene, polyethylene, polyurethane, polysaccharide, or cellulosic material) with quaternary ammonium phosphate inner salt having a reactive functional group; contact lenses; blood filtration BIOCOMPATIBLES LIMITED (GB) 1995-06-06 US disclosed
EP-0518959-A1 METHOD OF IMPROVING THE OCULAR HAEMO AND BIOCOMPATIBILITY OF SYNTHETIC POLYMERS. BIOCOMPATIBLES LTD (GB) 1992-12-23 EP disclosed
WO-1991013639-A1 METHOD OF IMPROVING THE OCULAR HAEMO AND BIOCOMPATIBILITY OF SYNTHETIC POLYMERS BIOCOMPATIBLES LIMITED (GB) 1991-09-19 WO disclosed